A detailed history of Garden State Investment Advisory Services LLC transactions in Greenwich Life Sciences, Inc. stock. As of the latest transaction made, Garden State Investment Advisory Services LLC holds 17,600 shares of GLSI stock, worth $216,128. This represents 0.07% of its overall portfolio holdings.

Number of Shares
17,600
Holding current value
$216,128
% of portfolio
0.07%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$12.99 - $17.58 $228,624 - $309,407
17,600 New
17,600 $253 Million

Others Institutions Holding GLSI

About Greenwich LifeSciences, Inc.


  • Ticker GLSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,848,200
  • Market Cap $158M
  • Description
  • Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...
More about GLSI
Track This Portfolio

Track Garden State Investment Advisory Services LLC Portfolio

Follow Garden State Investment Advisory Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Garden State Investment Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Garden State Investment Advisory Services LLC with notifications on news.